Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 84Lymphoma, Non-Hodgkin 71Lymphoma 62Lymphoma, Follicular 58Lymphoma, Mantle-Cell 57Lymphoma, Large B-Cell, Diffuse 40Multiple Myeloma 36Hodgkin Disease 30Lymphoma, B-Cell, Marginal Zone 28Recurrence 27Lymphoma, B-Cell 19Leukemia 18Waldenstrom Macroglobulinemia 14Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms, Plasma Cell 8Lymphoma, T-Cell 7Leukemia, Myeloid, Acute 7Burkitt Lymphoma 7Lymphoma, T-Cell, Peripheral 6Leukemia, B-Cell 6Hematologic Neoplasms 6Sezary Syndrome 5Myelodysplastic Syndromes 5Mycosis Fungoides 5Immune System Diseases 5Small Cell Lung Carcinoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Brentuximab Vedotin 4fludarabine 1Triamcinolone Acetonide 1Mechlorethamine 1Lenalidomide 1Bexarotene 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphomatoid Papulosis × Bendamustine Hydrochloride × Clear all
NCT03602157 2026-01-06

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

UNC Lineberger Comprehensive Cancer Center

Phase 1 Active not recruiting
43 enrolled
DermatologicLymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡